DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo

Novartis (NYSE: NVS)

company name or ticker
Company Photos
(Click to zoom)

Health Care Sector Update for 02/13/2015: TIPT, NVS

Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

Incyte Posts Wider-than-Expected Q4 Loss; Revenues Miss - Analyst Blog

Pfizer Takes A Giant Leap In Treatment of Cancer

5 Things GlaxoSmithKline PLC's Management Wants You to Know

GlaxoSmithKline's revenue fell 10% in the fourth quarter from the prior-year quarter, but this top-line figure doesn't give you the full story. However, this conference call with its management team sure does!

Glaxo Tries To Turn A Triple Play

Roche's Lucentis Gets FDA Nod for Diabetic Retinopathy - Analyst Blog

AstraZeneca Might Need More Than Buzzwords To Bridge The Gap

New Lifetime High Reached: Novartis (NVS)

AstraZeneca plc Beefs Up Precision Medicine Arsenal

AstraZeneca upped the ante in precision medicine with the announcement of four new collaborations.
See More Articles...